These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34363414)

  • 81. Permanent pacemaker implantation following aortic valve replacement: current prevalence and clinical predictors.
    Huynh H; Dalloul G; Ghanbari H; Burke P; David M; Daccarett M; Machado C; David S
    Pacing Clin Electrophysiol; 2009 Dec; 32(12):1520-5. PubMed ID: 19804492
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Changes in atrioventricular conduction and predictors of pacemaker need after percutaneous implantation of the CoreValve®. Aortic valve prosthesis.
    Muñoz-García AJ; Hernández-García JM; Jiménez-Navarro MF; Alonso-Briales JH; Rodríguez-Bailón I; Peña-Hernández J; Fernández-Pastor J; Domínguez-Franco AJ; Barrera-Cordero A; Alzueta-Rodríguez J; de Teresa Galván E
    Rev Esp Cardiol; 2010 Dec; 63(12):1444-51. PubMed ID: 21144405
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Implications of Transcatheter Heart Valve Selection on Early and Late Pacemaker Rate and on Length of Stay.
    Sathananthan J; Ding L; Yu M; Catlin B; Chan A; Charania J; Cheung A; Cook R; Murdoch DJ; Della Siega A; Latham T; Lauck S; Polderman J; Robinson SD; Virani S; Wong D; Wood D; Ye J; Webb JG
    Can J Cardiol; 2018 Sep; 34(9):1165-1173. PubMed ID: 30170672
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The future of transcatheter aortic valve implantation.
    Hamm CW; Arsalan M; Mack MJ
    Eur Heart J; 2016 Mar; 37(10):803-10. PubMed ID: 26578195
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Incidence and Predictors of Pacemaker Implantation in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Maan A; Refaat MM; Heist EK; Passeri J; Inglessis I; Ptaszek L; Vlahakes G; Ruskin JN; Palacios I; Sundt T; Mansour M
    Pacing Clin Electrophysiol; 2015 Jul; 38(7):878-86. PubMed ID: 25940067
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice: The RESPOND Study and RESPOND Extension Cohort.
    Van Mieghem NM; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Linke A; Ince H; Wenaweser P; Allocco DJ; Meredith IT; Falk V
    JACC Cardiovasc Interv; 2019 Jan; 12(1):38-49. PubMed ID: 30621976
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience.
    Rampat R; Khawaja MZ; Hilling-Smith R; Byrne J; MacCarthy P; Blackman DJ; Krishnamurthy A; Gunarathne A; Kovac J; Banning A; Kharbanda R; Firoozi S; Brecker S; Redwood S; Bapat V; Mullen M; Aggarwal S; Manoharan G; Spence MS; Khogali S; Dooley M; Cockburn J; de Belder A; Trivedi U; Hildick-Smith D
    JACC Cardiovasc Interv; 2017 Jun; 10(12):1247-1253. PubMed ID: 28641846
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Transapical transcatheter aortic valve implantation using a new second-generation TAVI system - J-Valve™ for high-risk patients with aortic valve diseases: Initial results with 90-day follow-up.
    Zhu D; Chen Y; Guo Y; Hu J; Zhang J; Wei X; Tang H; Shi Y
    Int J Cardiol; 2015 Nov; 199():155-62. PubMed ID: 26197402
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Long-Term Mortality Effect of Early Pacemaker Implantation After Surgical Aortic Valve Replacement.
    Greason KL; Lahr BD; Stulak JM; Cha YM; Rea RF; Schaff HV; Dearani JA
    Ann Thorac Surg; 2017 Oct; 104(4):1259-1264. PubMed ID: 28433222
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Reply to Tomšič and Klautz.
    Barili F; Gerosa G; Parolari A
    Eur J Cardiothorac Surg; 2020 Nov; 58(5):1105-1106. PubMed ID: 32535619
    [No Abstract]   [Full Text] [Related]  

  • 92. Incidence, indications and predicting factors of permanent pacemaker implantation after transcatheter aortic valve implantation: A retrospective study.
    Becker M; Blangy H; Folliguet T; Villemin T; Freysz L; Luc A; Maureira P; Popovic B; Olivier A; Sadoul N
    Arch Cardiovasc Dis; 2017 Oct; 110(10):508-516. PubMed ID: 28647466
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Impact of Aortomitral Continuity Calcification on Need for Permanent Pacemaker After Transcatheter Aortic Valve Replacement.
    Katchi F; Bhatt D; Markowitz SM; Szymonifka J; Cheng EP; Minutello RM; Bergman GW; Wong SC; Salemi A; Truong QA
    Circ Cardiovasc Imaging; 2019 Dec; 12(12):e009570. PubMed ID: 31813271
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [New conduction disturbances and pacemaker indications after CoreValve® transcatheter aortic valve replacement. Incidence and follow up in a single center experience].
    Aversa E; Muratore CA; Nemesio ML; Tentori MC; Payaslian M
    Arch Cardiol Mex; 2015; 85(4):278-83. PubMed ID: 25772651
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Three-Year Survival Comparison Between Transcatheter and Surgical Aortic Valve Replacement for Intermediate- and Low-Risk Patients.
    Siordia JA; Loera JM; Scanlon M; Evans J; Knight PA
    Innovations (Phila); 2018; 13(3):153-162. PubMed ID: 29912140
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Oversizing Increases Pacemaker Implantation Rate After Sutureless Minimally Invasive Aortic Valve Replacement.
    Geršak B; Glauber M; Bouchard D; Jug J; Solinas M
    Innovations (Phila); 2020; 15(5):449-455. PubMed ID: 32758051
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Indications and predictors for pacemaker implantation after isolated aortic valve replacement with bioprostheses: the CAREAVR study.
    Salmi SJ; Nieminen T; Hartikainen J; Biancari F; Lehto J; Nissinen M; Malmberg M; Yannopoulos F; Savolainen J; Airaksinen J; Kiviniemi T
    Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):398-404. PubMed ID: 32747953
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Permanent pacemaker implantation and paravalvular leak rates following sutureless aortic valve operations.
    Lazkani M; Yerasi C; Prakash S; Pershad A; Fang K
    J Card Surg; 2018 Dec; 33(12):808-817. PubMed ID: 30548698
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Conduction disturbances and permanent cardiac pacing after transcatheter implantation of the CoreValve aortic bioprosthesis: initial single centre experience.
    Czerwińska K; Hryniewiecki T; Oręziak A; Dąbrowski M; Michałowska I; Witkowski A; Demkow M; Stępińska J; Orłowska Baranowska E; Rużyłło W
    Kardiol Pol; 2012; 70(2):121-8. PubMed ID: 22427074
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Dynamic nomogram for predicting pacemaker implantation following transcatheter aortic valve replacement.
    Truong VT; Beyerbach D; Mazur W; Wigle M; Pallerla A; Bateman E; Ngo TNM; Shreenivas S; Palmer C; Tretter JT; Kereiakes DJ; Chung ES
    Pacing Clin Electrophysiol; 2021 Jul; 44(7):1277-1278. PubMed ID: 33956352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.